1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow T2D: new trials by email Literature Review of T2D trials Research Report on T2D
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes Tirzepatide, Placebo - Overweight, Obesity | Phase 2 | Completed | Eli Lilly and Company | 134 | 2023-02-08 | 2026-09-11 |
Diabetes Mellitus, Type 2 (1) · Obesity (1) · Overweight (1) · Renal Insufficiency, Chronic (1)
Body Weight (1) · Chronic Disease (1) · Diabetes Mellitus (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glucose Metabolism Disorders (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Metabolic Diseases (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathologic Processes (1)
Tirzepatide (1)
Austria (1) · Canada (1) · Denmark (1) · Mexico (1) · Netherlands (1) · United States (1)
2023 (1)